These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12047344)
1. Stadol nasal spray for headache. Robbins L Headache; 2002 May; 42(5):386. PubMed ID: 12047344 [No Abstract] [Full Text] [Related]
2. Comparison of stadol NS and fiorinal with codeine. Sohn RS Headache; 1999 Feb; 39(2):137-8. PubMed ID: 18564449 [No Abstract] [Full Text] [Related]
3. Post-marketing experience with an opioid nasal spray for migraine: lessons for the future. Loder E Cephalalgia; 2006 Feb; 26(2):89-97. PubMed ID: 16426261 [TBL] [Abstract][Full Text] [Related]
4. Stadol Nasal Spray--treatment for migraine? Robbins L Headache; 1993 Apr; 33(4):220. PubMed ID: 8496065 [No Abstract] [Full Text] [Related]
5. Transnasal butorphanol in the emergency department management of migraine headache. Melanson SW; Morse JW; Pronchik DJ; Heller MB Am J Emerg Med; 1997 Jan; 15(1):57-61. PubMed ID: 9002572 [TBL] [Abstract][Full Text] [Related]
6. Transnasal butorphanol in the treatment of acute migraine. Hoffert MJ; Couch JR; Diamond S; Elkind AH; Goldstein J; Kohlerman NJ; Saper JR; Solomon S Headache; 1995 Feb; 35(2):65-9. PubMed ID: 7737863 [TBL] [Abstract][Full Text] [Related]
7. Migraine research methods. Fisher H CMAJ; 1997 Oct; 157(8):1015-6, 1018. PubMed ID: 9347769 [No Abstract] [Full Text] [Related]
8. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816 [TBL] [Abstract][Full Text] [Related]
9. Butorphanol (Stadol): a study in problems of current drug information and control. Fisher MA; Glass S Neurology; 1997 May; 48(5):1156-60. PubMed ID: 9153436 [TBL] [Abstract][Full Text] [Related]
13. Opioid therapy and headache: a cause and a cure. Lipton RB; Bigal ME Neurology; 2004 May; 62(10):1662-3. PubMed ID: 15159457 [No Abstract] [Full Text] [Related]
14. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501 [TBL] [Abstract][Full Text] [Related]
15. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management. Gillis JC; Benfield P; Goa KL Drugs; 1995 Jul; 50(1):157-75. PubMed ID: 7588085 [TBL] [Abstract][Full Text] [Related]
16. [The role of opioids in the treatment of primary headache disorders]. Totzeck A; Gaul C Schmerz; 2014 Apr; 28(2):135-40. PubMed ID: 24500765 [TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration. Vachharajani NN; Shyu WC; Nichola PS; Boulton DW Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090 [TBL] [Abstract][Full Text] [Related]